About this trial
This study aimed to compare the efficacy of punctured electrocoagulation and sclerotherapy in the treatment of incompetent perforator veins.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
treatment: puncture of coagulation
Procedure/Surgeryultrasound-guided puncture of coagulation
treatment: sclerosing agent injected
Procedure/Surgeryultrasound-guided sclerosing agent injected
Treatment groups
Trial outcomes
Primary outcomes
IPVs occlusion rate in the 12th month.
IPVs occlusion rate is defined as DS \> 50% for each modality with no procedure no procedure performed on the treated segment
Secondary outcomes
Quality of life scale survey results
quality of life scale survey results (CEAP classification, VCSS score, CIVIQ-14 score).Quality of life will be assessed by MOS item short-form health survey scale (SF-36). SF-36 includes eight subscales: physical functioning (PF, 10 items), role limitations due to physical health problems (RL-P, 4 items), bodily pain (BP, 2 items), general health (GH, 5 items), vitality (V, 4 items), social functioning (SF, 2 items), role limitations due to emotional problems (RL-E, 3 items) and mental health (MH, 5 items). The vitality sub-score assesses energy and fatigue, and ranges from 0 (worst) - 100 (best).
Skin ulcer recurrence rate
Skin ulcer recurrence
Proportion of participants with deep venous Thrombosis
deep venous Thrombosis
Proportion of participants with hemorrhage
Including hemorrhagic stroke, gastrointestinal bleeding, hematuria, mucocutaneous hemorrhage and other visceral bleeding
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead sponsor
Sir Run Run Shaw Hospital
Collaborator
Shanghai Zhongshan Hospital
Collaborator
Yantai Yuhuangding Hospital
Collaborator
Anhui Provincial Hospital
Collaborator